These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9383377)

  • 21. Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance.
    Payne G; Shoelson SE; Gish GD; Pawson T; Walsh CT
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4902-6. PubMed ID: 7685110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining the specificity space of the human SRC homology 2 domain.
    Huang H; Li L; Wu C; Schibli D; Colwill K; Ma S; Li C; Roy P; Ho K; Songyang Z; Pawson T; Gao Y; Li SS
    Mol Cell Proteomics; 2008 Apr; 7(4):768-84. PubMed ID: 17956856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity.
    Shakespeare W; Yang M; Bohacek R; Cerasoli F; Stebbins K; Sundaramoorthi R; Azimioara M; Vu C; Pradeepan S; Metcalf C; Haraldson C; Merry T; Dalgarno D; Narula S; Hatada M; Lu X; van Schravendijk MR; Adams S; Violette S; Smith J; Guan W; Bartlett C; Herson J; Iuliucci J; Weigele M; Sawyer T
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9373-8. PubMed ID: 10944210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal Structures and Thermodynamic Analysis Reveal Distinct Mechanisms of CD28 Phosphopeptide Binding to the Src Homology 2 (SH2) Domains of Three Adaptor Proteins.
    Inaba S; Numoto N; Ogawa S; Morii H; Ikura T; Abe R; Ito N; Oda M
    J Biol Chem; 2017 Jan; 292(3):1052-1060. PubMed ID: 27927989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of phosphopeptides containing iminodiacetate groups as binding ligands of the Src SH2 domain.
    Ye G; Schuler AD; Ahmadibeni Y; Morgan JR; Faruqui A; Huang K; Sun G; Zebala JA; Parang K
    Bioorg Chem; 2009 Aug; 37(4):133-42. PubMed ID: 19539345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational basis for SH2-Tyr(P)527 binding in Src inactivation.
    Ayrapetov MK; Wang YH; Lin X; Gu X; Parang K; Sun G
    J Biol Chem; 2006 Aug; 281(33):23776-84. PubMed ID: 16790421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High resolution crystal structure of the Grb2 SH2 domain with a phosphopeptide derived from CD28.
    Higo K; Ikura T; Oda M; Morii H; Takahashi J; Abe R; Ito N
    PLoS One; 2013; 8(9):e74482. PubMed ID: 24098653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SH2 domains recognize specific phosphopeptide sequences.
    Songyang Z; Shoelson SE; Chaudhuri M; Gish G; Pawson T; Haser WG; King F; Roberts T; Ratnofsky S; Lechleider RJ
    Cell; 1993 Mar; 72(5):767-78. PubMed ID: 7680959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of affinities for lck SH2 binding peptides using a sensitive fluorescence assay: comparison between the pYEEIP and pYQPQP consensus sequences reveals context-dependent binding specificity.
    Cousins-Wasti RC; Ingraham RH; Morelock MM; Grygon CA
    Biochemistry; 1996 Dec; 35(51):16746-52. PubMed ID: 8988011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of peptide molecular recognition by phospholipase C gamma-1 Src homology-2 domain and a mutant Tyr phosphatase PTP1bC215S.
    MacLean D; Sefler AM; Zhu G; Decker SJ; Saltiel AR; Singh J; McNamara D; Dobrusin EM; Sawyer TK
    Protein Sci; 1995 Jan; 4(1):13-20. PubMed ID: 7773170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and biophysical investigation of the interaction of a mutant Grb2 SH2 domain (W121G) with its cognate phosphopeptide.
    Papaioannou D; Geibel S; Kunze MB; Kay CW; Waksman G
    Protein Sci; 2016 Mar; 25(3):627-37. PubMed ID: 26645482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis for specificity switching of the Src SH2 domain.
    Kimber MS; Nachman J; Cunningham AM; Gish GD; Pawson T; Pai EF
    Mol Cell; 2000 Jun; 5(6):1043-9. PubMed ID: 10911998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative modes of tyrosyl phosphopeptide binding to a Src family SH2 domain: implications for regulation of tyrosine kinase activity.
    Ladbury JE; Hensmann M; Panayotou G; Campbell ID
    Biochemistry; 1996 Aug; 35(34):11062-9. PubMed ID: 8780508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-terminal carboxyl and tetrazole-containing amides as adjuvants to Grb2 SH2 domain ligand binding.
    Burke TR; Yao ZJ; Gao Y; Wu JX; Zhu X; Luo JH; Guo R; Yang D
    Bioorg Med Chem; 2001 Jun; 9(6):1439-45. PubMed ID: 11408162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.
    Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER
    Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
    Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
    J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of the binding specificity of the SH2 domains of protein tyrosine phosphatase SHP-1 through the screening of a combinatorial phosphotyrosyl peptide library.
    Beebe KD; Wang P; Arabaci G; Pei D
    Biochemistry; 2000 Oct; 39(43):13251-60. PubMed ID: 11052678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carboxymethyl-phenylalanine as a replacement for phosphotyrosine in SH2 domain binding.
    Tong L; Warren TC; Lukas S; Schembri-King J; Betageri R; Proudfoot JR; Jakes S
    J Biol Chem; 1998 Aug; 273(32):20238-42. PubMed ID: 9685372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.
    Imhof D; Wieligmann K; Hampel K; Nothmann D; Zoda MS; Schmidt-Arras D; Zacharias M; Böhmer FD; Reissmann S
    J Med Chem; 2005 Mar; 48(5):1528-39. PubMed ID: 15743195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.